
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 737789-87-6 | 货号 | BCP21587 |
中文名 | 瑞卢戈利 | ||
英文名 | Relugolix | ||
中文别名 | |||
英文别名 | TAK385; TAK-385;TAK-385; | ||
SMILES | CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC | ||
化学名称 | |||
分子式 | C29H27F2N7O5S | 分子量 | 623.63 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | elugolix, also known as TAK-385, is a luteinizing hormone-releasing hormone (LH-RH) receptor antagonist administered orally. By preventing LH-RH from binding with the LH-RH receptor in the anterior pituitary gland and suppressing the secretion of luteinizing hormone (LH) and follicle stimulation hormone (FSH) from the anterior pituitary gland, TAK-385 controls the effect of LH and FSH on the ovary, reduces the level of estrogen in blood, which is known to be associated with the development of endometriosis and uterine fibroids, and is expected to improve the symptoms of these disorders. |
Tags:Relugolix 供应商,Relugolix 购买,Relugolix 生产,Relugolix 批量,Relugolix 供应,Relugolix 订购,Relugolix 采购